Level of Continuous Positive Airway Pressure (CPAP) in Preterm Infants After Extubation (L-CPAP Study)

Hamilton Health Sciences (HHS)

Status and phase: Terminated; Phase 2

Conditions: Respiratory Insufficiency of Prematurity

Treatments: Device: Nasal CPAP, level 7 to 9 cmH2O; Device: Nasal CPAP, level 4 to 6 cmH2O

Study type: Interventional

Funder types: Other

Identifiers

NCT00636324

REB project # 07-047

Details and patient eligibility

About

Despite widely used of nasal CPAP in preterm infants, uncertainties regarding aspects of its application remain. Clinical indications vary greatly between institutions, especially when combined with varieties of systems, devices, and techniques available. One of the controversial aspects that needs to be clarified is the level of pressure which should be used. The objective of the study is to compare the effectiveness of two ranges of nCPAP pressure that are within the spectrum of current practice for post-extubation support in very preterm infants.

Full description

The use of nCPAP has been established as an effective respiratory support to prevent extubation failure and as treatment of other pulmonary diseases. An upsurge in its popularity has resulted in some controversial aspects, including the level of pressure to be used. The level that has been used in very preterm infants after extubation, which mostly came from anecdotal data, varies from 3 to 10 cmH2O.

Physiologic studies show higher nCPAP pressures improve lung mechanical properties. Though potential side effects have been of concern in practical application, there is no formal evidence supporting the concept that increased CPAP pressure results in a higher risk of complications. In relatively stable preterm infants, the range of optimal CPAP level needs to be established in order to adequately support the upper airway and lungs, without increasing complications secondary to the pressure applied. Given the uncertainty of the nCPAP pressure that should be used in very preterm infants, we conduct a randomized controlled trial to compare the effectiveness of two ranges of nCPAP pressure for post-extubation support in very preterm infants.

The purpose of this trial is to compare the rate of successful extubation of using the nasal CPAP level of 7 to 9 cmH2O compared to level of 4 to 6 cmH2O.

Enrollment: 23 patients

Sex: All

Ages: Under 14 days old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Birth weight 500 - 1,250 g
• On mechanical ventilation before 7 days of age
• First extubation before 14 days of age

Exclusion criteria

• Presence of lethal anomalies or upper airway abnormalities
• IVH, grade 3 or 4
• Neuromuscular disorders
• Receiving muscle relaxation at time of extubation
• Congenital heart disease, except for PDA
• GI problems resulting in a need to avoid gastric distension

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

23 participants in 2 patient groups

1

Experimental group

Description:

Nasal CPAP, level of 7 to 9 cmH2O

Treatment:

Device: Nasal CPAP, level 7 to 9 cmH2O

2

Active Comparator group

Description:

Nasal CPAP, level 4 to 6 cmH2O

Treatment:

Device: Nasal CPAP, level 4 to 6 cmH2O